Avolio, Alfonso Wolfango
 Distribuzione geografica
Continente #
EU - Europa 4.762
NA - Nord America 4.426
AS - Asia 2.070
SA - Sud America 369
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 11.670
Nazione #
US - Stati Uniti d'America 4.350
DE - Germania 1.470
CN - Cina 891
SE - Svezia 885
SG - Singapore 705
IT - Italia 554
UA - Ucraina 527
BR - Brasile 338
FR - Francia 290
IE - Irlanda 261
GB - Regno Unito 233
PL - Polonia 154
FI - Finlandia 146
ID - Indonesia 141
RU - Federazione Russa 78
TR - Turchia 74
IN - India 68
CA - Canada 55
BE - Belgio 43
KR - Corea 40
HK - Hong Kong 36
IR - Iran 27
JP - Giappone 20
NL - Olanda 17
MX - Messico 16
LT - Lituania 15
AT - Austria 14
VN - Vietnam 14
AR - Argentina 12
ES - Italia 12
RO - Romania 12
CH - Svizzera 11
EU - Europa 10
CZ - Repubblica Ceca 9
BD - Bangladesh 8
AU - Australia 7
IQ - Iraq 7
ZA - Sudafrica 7
EC - Ecuador 6
UZ - Uzbekistan 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
AZ - Azerbaigian 4
DK - Danimarca 4
EE - Estonia 4
MA - Marocco 4
PK - Pakistan 4
PT - Portogallo 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CL - Cile 3
EG - Egitto 3
MD - Moldavia 3
PA - Panama 3
SA - Arabia Saudita 3
UY - Uruguay 3
VE - Venezuela 3
GR - Grecia 2
KG - Kirghizistan 2
LV - Lettonia 2
MU - Mauritius 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
TW - Taiwan 2
AO - Angola 1
BH - Bahrain 1
BZ - Belize 1
CO - Colombia 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PE - Perù 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 11.670
Città #
Chandler 770
Ashburn 428
Singapore 365
Jacksonville 285
Dublin 253
San Mateo 235
Ann Arbor 177
Nanjing 153
Jakarta 139
Rome 126
Wilmington 119
Munich 115
Boston 108
Beijing 102
Warsaw 99
Marseille 96
New York 96
Woodbridge 90
Milan 86
The Dalles 84
Mcallen 83
Lawrence 82
Seattle 82
Dearborn 77
Nürnberg 72
Bremen 68
Houston 68
Redwood City 68
Fairfield 64
Nanchang 61
Izmir 59
Moscow 52
Shenyang 52
Cattolica 49
Princeton 47
Chicago 45
Hangzhou 45
Frankfurt am Main 44
Hebei 42
Helsinki 42
University Park 41
Zhengzhou 40
Brussels 39
Lancaster 36
Andover 33
Los Angeles 31
Tianjin 31
Kraków 30
Hong Kong 28
Mountain View 28
Hefei 27
Kunming 27
Changsha 25
Augusta 24
Montréal 24
Guangzhou 23
Seoul 23
Shanghai 23
London 22
Norwalk 22
São Paulo 21
Nuremberg 20
Jiaxing 19
Ningbo 18
Chengdu 17
Fremont 17
Hounslow 17
Kish 17
Pune 16
Cambridge 15
Detroit 15
Boardman 14
Toronto 14
Belo Horizonte 12
Jinan 12
Rio de Janeiro 12
Santa Clara 12
San Giovanni Bianco 11
Düsseldorf 10
Lauterbourg 10
San Diego 10
Curitiba 9
Leawood 9
Portsmouth 9
Seongnam 9
North Bergen 8
Salvador 8
Santa Maria 8
Segrate 8
Vienna 8
Berlin 7
Changchun 7
Falls Church 7
Mexico City 7
Paris 7
Redmond 7
Timisoara 7
Washington 7
Ardabil 6
Atlanta 6
Totale 6.158
Nome #
Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study 368
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 305
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 256
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 173
Duplex Doppler in the postoperative monitoring of liver transplant recipients 168
Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation 166
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 164
Accidental transplantation of a kidney with stones: case report 160
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 150
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 150
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 149
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 142
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 129
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 125
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 124
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 122
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 121
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 120
Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients 117
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 116
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 115
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 115
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 114
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 112
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 112
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 111
Model for end-stage liver disease dynamic stratification of survival benefit 111
Prediction of 6-month survival after liver transplantation using Cox regression. 109
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 109
Liver transplantation in patients with alcoholic liver disease: A retrospective study 108
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 105
Psychological risk factors for graft rejection among liver transplant recipients 103
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 102
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 102
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 101
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 101
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 99
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 99
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 96
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 95
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 94
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 92
A Bayesan methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. 92
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 91
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 90
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 90
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 89
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 88
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 88
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 88
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 87
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 87
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 86
Is primary nonfunction still a suitable indication for liver retransplantation? 85
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 84
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 84
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 83
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 82
L-GrAFT and EASE scores in liver transplantation. Need for a reciprocal external validation and comparison with other scores 82
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 81
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 80
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 80
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 79
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 78
Primary difunction after liver trasplantation: donor or recipients fault? 78
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 78
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 76
Clinical problems of the transplanted kidney 75
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 75
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 75
Celiac axis compression syndrome in liver transplantation 74
High-Flow Nasal Cannula Versus Standard Oxygen Therapy After Extubation in Liver Transplantation: A Matched Controlled Study 74
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 74
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 73
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 73
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 73
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 72
Balancing Utility and Need by Means of Donor-to-Recipient Matching: A Challenging Problem. 71
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 69
Should retransplantation still be considered for primary non-function after liver transplantation? 69
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 69
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 69
Viscoelastic versus conventional coagulation tests to reduce blood product transfusion in patients undergoing liver transplantation: A systematic review and meta-analysis 68
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs. 68
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 67
Use of O blood group liver donors for nonidentical recipients: does this represent a double penalty for O blood group candidates? 67
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 67
Cefotetan versus cefoxitin in peritonitis 66
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 65
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients 65
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 65
Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation 63
Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant. 62
Marginal donors for patients on regular waiting lists for liver transplantation 61
Recovery index: a useful tool for quantification of liver injury after liver transplantation to predict one-year survival 60
Outcome of liver transplatation after acute rejection and sepsis 60
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 60
Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. 59
Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27 58
Safety of long term biologic therapy in rheumatologic patients with a previously resolved HBV infection 58
Totale 9.960
Categoria #
all - tutte 52.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020238 0 0 0 0 0 0 0 0 0 0 124 114
2020/20211.111 81 114 14 112 169 50 114 19 132 71 212 23
2021/20221.377 85 188 32 108 66 52 11 226 60 56 220 273
2022/20232.323 279 300 219 346 139 291 132 185 252 55 100 25
2023/20241.184 48 378 25 159 54 118 82 38 15 54 106 107
2024/20252.131 45 61 199 95 202 113 66 97 414 282 557 0
Totale 11.797